THERA NEUROPHARMA

thera-neuropharma-logo

Thera is a biotechnology company dedicated to the discovery, development and commercialization of impactful therapeutic interventions for neurodegenerative disorders. Our regenerative molecules and RNA-based compounds are therapeutics potentially disease-modifying for a fatal disease, Amyotrophic Lateral Sclerosis (ALS), and a severely disabling condition, Traumatic Brain Injury (TBI).

#SimilarOrganizations #Website #More

THERA NEUROPHARMA

Industry:
Biotechnology

Address:
Berwyn, Pennsylvania, United States

Country:
United States

Website Url:
http://www.theraneuro.com

Status:
Active

Contact:
610.761.7311

Email Addresses:
[email protected]

Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright


Similar Organizations

hepatera-logo

Hepatera

Hepatera is a biotechnology company.

Official Site Inspections

http://www.theraneuro.com

  • Host name: ec2-52-86-6-113.compute-1.amazonaws.com
  • IP address: 52.86.6.113
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Thera Neuropharma"

Thera neuropharma

Competitive Advantage. Thera Neuropharma is advancing an innovative approach that employs two complementary technologies. Our small molecule regenerative therapy (SMRT) and self โ€ฆSee details»

Thera Neuropharma - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 610.761.7311 Thera is a biotechnology company dedicated to the discovery, development and commercialization of impactful โ€ฆSee details»

LEADERSHIP - Thera NeuroPharma

Mr. Maestre serves as ad interim Chief Executive Officer and Chief Operating Officer of the Company. He is a co-Founder, Board member and Corporate Secretary of the company. He brings over 30 years of pharmaceutical and โ€ฆSee details»

Thera Neuropharma, Inc. - Drug pipelines, Patents, Clinical

Theraneuro.com. Subsidiary Company | Pennsylvania, United States | theraneuro.com. Last update 19 Sep 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics โ€ฆSee details»

Thera Neuropharma - VentureRadar

"Thera Neuropharma investigates the use of small molecules and RNA-based compounds as therapeutics to treat Amyotrophic Lateral Sclerosis (ALS) and Traumatic Brain Injury (TBI).See details»

Investors - Thera NeuroPharma

โ€ขGrowing prevalence of neurodegenerative diseases in elderly population โ€ข Orphan drug pricing structure: โ€ข market size: $1.1 B for ALS (ww) $3.8 B for TBI (USA) โ€ข Increase disease โ€ฆSee details»

Thera Neuropharma - Overview, News & Similar companies

Thera Neuropharma contact info: Phone number: (610) 761-7311 Website: www.theraneuro.com What does Thera Neuropharma do? Thera NeuroPharma. Our lead candidates are disease โ€ฆSee details»

Theraneuro - Company Profile - Tracxn

Theraneuro - Developing small molecules that upregulate neuroprotective pathway for the treatment of neurologic disorders, initially focusing on ALS and TBI. Raisedfunding over 1 โ€ฆSee details»

Thera Neuropharma - Wiki - Golden

Thera Neuropharma is a Berwyn, Pennsylvania-based company. Overview Structured Data Issues Contributors Activity. ContentsSee details»

Theraneuro | Founders and Board of Directors - Tracxn

List of Founders and Board of members of TheraneuroSee details»

Thera Neuropharma - Craft

Thera Neuropharma has 1 employees at their 1 location. See insights on Thera Neuropharma including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆSee details»

Theraneuro - Raised Funding from 1 investor - Tracxn

Theraneuro has raisedfunding over 1 round from 1 investor. Investor includes VLAIO. Their latest funding round was of $1.27M on May 09, 2016 .See details»

Theraneuro Security Rating - SecurityScorecard

View Theraneuro's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving TheraneuroSee details»

Research and Development - Thera NeuroPharma

Thera has selected two lead chemical compounds, SYN1 and SYN2, and has already performed preliminary research to characterize their pharmacology, drug distribution, animal efficacy and โ€ฆSee details»

RXi Pharmaceuticals and Thera Neuropharma Enter into an โ€ฆ

MARLBOROUGH, Mass., May 3, 2016 /PRNewswire/ -- RXi Pharmaceuticals Corporation (RXi) (NASDAQ: RXII) and privately-held Thera Neuropharma, Inc. (Thera) announced today that โ€ฆSee details»

Thera neuropharma | Research and Development

Thera NeuroPharma. Our lead candidates are disease-modifying therapeutics for a fatal disease, Amyotrophic Lateral Sclerosis (ALS), and a severely disabling condition, Traumatic Brain โ€ฆSee details»

Theraneuro - 405 Competitors and alternatives in May 2024 - Tracxn

Theraneuro has 405 active competitors. Competitors include Biogen, Amylyx Pharmaceuticals.See details»

Tetraneuron - Crunchbase Company Profile & Funding

Tetraneuron is a drug discovery company in treating brain and neurodegenerative conditions.See details»

Press Release - Thera NeuroPharma

Thera Neuropharma Awarded Funding from Flemish Agency For Innovation And Entrepeneurship - Vlaamse Agentschap Innoveren En Ondernemen (VLAIO) . Berwyn, PA, May 9, 2016/ โ€ฆSee details»

Technology - Thera NeuroPharma

Technology Platforms. The small molecule regenerative therapy (SMRT) technology uncovers the therapeutic potential of dual-target approach leveraging the direct activation of the nuclear โ€ฆSee details»

linkstock.net © 2022. All rights reserved